“脑机接口”战略合作框架协议涉嫌误导性陈述，亚辉龙被证监会立案！上月刚被上交所警示

Core Viewpoint - The company YHLO (SH688575) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, following a previous warning from the Shanghai Stock Exchange regarding inaccurate disclosures related to a strategic cooperation agreement [1][3]. Group 1: Regulatory Actions - YHLO received a notice from the CSRC on February 6, indicating that the company is under investigation for alleged violations of the Securities Law and the Administrative Penalty Law of the People's Republic of China [1][3]. - The investigation stems from a January 7 announcement regarding a strategic cooperation framework agreement, which was found to contain misleading statements [1][3]. - The Shanghai Stock Exchange had previously issued a regulatory warning to YHLO's then-Secretary of the Board, highlighting issues of inaccurate and incomplete information disclosure [3][4]. Group 2: Financial Performance - YHLO's 2025 earnings forecast indicates a significant decline, with expected net profit attributable to shareholders dropping over 90% compared to the previous year, projecting between 20 million to 30 million yuan, down from approximately 300 million yuan in 2024 [5][6]. - The company attributes the decline in performance to industry policy impacts, resulting in reduced domestic market demand and lower revenue and gross margin [6][7]. - Additionally, YHLO reported losses from its trading financial assets, specifically from its holdings in Cloud Health Group Limited, and plans to recognize impairment losses on various assets [6][7]. Group 3: Business Operations - Despite domestic challenges, YHLO has achieved some success in overseas markets, with stable growth in international marketing and ongoing efforts in product development and market access [7]. - The company has completed the highest level (Class D) IVDR CE certification for its full range of preoperative chemiluminescence testing reagents, indicating progress in its product offerings [7].